Soleno Therapeutics Inc (SLNO): Next-Year EPS Estimate 61.21%
As of 2026-05-20, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 61.21%. Featured in 2 EPS revision reports, most recently on 2026-04-13.
On 2026-05-19, analyst consensus for SLNO's next-year EPS growth shifted from 59.18% to 61.21% — a positive change of 2.03 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 877.21%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 61.21%
- EPS growth this year
- 877.21%
- EPS next quarter (est)
- $0.92
- Last price
- $53.01
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-20 | 61.21% | 877.21% | $0.92 | $53.01 |
| 2026-05-19 | 61.21% | 877.21% | $0.92 | $53.01 |
| 2026-05-18 | 59.18% | 912.39% | $0.94 | $53.01 |
| 2026-05-17 | 59.18% | 912.39% | $0.94 | $53.01 |
| 2026-05-14 | 59.18% | 912.39% | $0.94 | $52.99 |
| 2026-05-13 | 59.18% | 912.39% | $0.94 | $52.97 |
| 2026-05-12 | 59.18% | 912.39% | $0.94 | $52.93 |
| 2026-05-11 | 59.18% | 912.39% | $0.68 | $52.94 |
| 2026-05-10 | 59.18% | 912.39% | $0.68 | $52.95 |
| 2026-05-07 | 59.18% | 912.39% | $0.68 | $52.95 |
| 2026-05-06 | 59.18% | 912.39% | $0.68 | $52.94 |
| 2026-05-05 | 59.18% | 912.39% | $0.68 | $52.92 |
| 2026-05-04 | 59.18% | 912.39% | $0.68 | $52.90 |
| 2026-05-03 | 59.18% | 912.39% | $0.68 | $52.87 |
| 2026-04-30 | 59.18% | 912.39% | $0.68 | $52.82 |
| 2026-04-29 | 59.18% | 912.39% | $0.68 | $52.78 |
| 2026-04-28 | 59.18% | 912.39% | $0.68 | $52.76 |
| 2026-04-27 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-26 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-24 | 59.18% | 912.39% | $0.68 | $52.72 |
| 2026-04-23 | 59.18% | 912.39% | $0.68 | $52.83 |
| 2026-04-22 | 59.18% | 912.39% | $0.68 | $52.75 |
| 2026-04-21 | 59.18% | 912.39% | $0.68 | $52.69 |
| 2026-04-20 | 59.18% | 912.39% | $0.68 | $52.67 |
| 2026-04-19 | 59.18% | 912.39% | $0.68 | $52.78 |
| 2026-04-16 | 59.18% | 912.39% | $0.68 | $52.57 |
| 2026-04-15 | 59.18% | 912.39% | $0.68 | $52.57 |
| 2026-04-14 | 59.18% | 912.39% | $0.68 | $52.62 |
| 2026-04-13 | 59.18% | 912.39% | $0.68 | $52.64 |
| 2026-04-12 | 59.18% | 912.39% | $0.68 | $52.63 |
Reports Featuring SLNO
Screen Performance
Aggregate stats across all 1713 tickers our top-EPS-revision screen has flagged over the past 49 days.
- Median return since detection
- +2.8%
- % of tickers in the green
- 58%
- Median return on winners
- +15.1%
- Large revisions captured
- 630
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Soleno Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-20, Soleno Therapeutics Inc (SLNO) has a next-year EPS growth estimate of 61.21%, based on analyst consensus.
When was the latest EPS estimate revision for SLNO?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 59.18% to 61.21%.
What sector and industry does Soleno Therapeutics Inc belong to?▾
Soleno Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SLNO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Soleno Therapeutics Inc (SLNO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports